- Ragweed Allergy
- Atrial Fibrillation
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study will evaluate the safety and effectiveness of an investigational drug. You must be 18 to 50 and have a history of ragweed allergy to qualify.
The research site is in Houston, Texas.
This study of atrial fibrillation is recruiting candidates. The research site is in Philadelphia, Penn.
This study will evaluate an investigational medication for psoriasis, a disorder that affects the skin and joints.
The research site is in Baltimore, Md.
Copyright 2009 ClinicalConnection.com. All rights reserved.
Copyright © 2011 HealthDay. All rights reserved.